ADAR1 Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.19M | Buy |
98,032
+85,232
| +666% | +$2.77M | 0.49% | 43 |
|
|
2025
Q1 | $483K | Buy |
+12,800
| New | +$483K | 0.09% | 101 |
|
|
2024
Q4 | – | Sell |
-10,097
| Closed | -$1.15M | – | 265 |
|
|
2024
Q3 | $1.15M | Sell |
10,097
-2,153
| -18% | -$246K | 0.19% | 58 |
|
|
2024
Q2 | $925K | Buy |
12,250
+10,250
| +513% | +$774K | 0.17% | 63 |
|
|
2024
Q1 | $137K | Buy |
2,000
+1,900
| +1,900% | +$130K | 0.03% | 122 |
|
|
2023
Q4 | $6.28K | Buy |
+100
| New | +$6.28K | ﹤0.01% | 121 |
|